Science Explorer Back to mapMap
Discussion
Company · Huddinge · Sweden

AlzeCure Pharma (Sweden)

alzecurepharma.se/enROR OpenAlex
Research works
12
▲ 96% vs 2018-21
Citations
154
13.2 per fractional work
Top-10% rate
18.0%
all institutions 10.0%
Open access
82%
world 40%
International
12%
world 18%
AlzeCure Pharma (Sweden)

Not ranked overall: AlzeCure Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AlzeCure Pharma (Sweden) work in?

In all years, 62% of research at AlzeCure Pharma (Sweden) is in Life Sciences, 33% in Health Sciences. Its largest fields are Neuroscience (36%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (26%). It does 2.2× the world's share of Life Sciences.

Life Sciences: 7 fractional works · 62.2% of its workNeuroscience: 4 fractional works · 35.6% of its workCellular and Molecular Neuroscience: 3 fractional works · 27.2% of its workDevelopmental Neuroscience: 1 fractional works · 5.6% of its workSensory Systems: 0 fractional works · 2.1% of its workCognitive Neuroscience: 0 fractional works · 0.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 25.7% of its workMolecular Biology: 3 fractional works · 23.4% of its workCancer Research: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 0.5% of its workAging: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.9% of its workHealth Sciences: 4 fractional works · 32.9% of its workMedicine: 4 fractional works · 32.9% of its workPhysiology: 1 fractional works · 7.1% of its workPharmacology: 1 fractional works · 5.7% of its workOncology: 1 fractional works · 4.6% of its workPsychiatry and Mental health: 0 fractional works · 4.3% of its workNeurology: 0 fractional works · 3.3% of its workSurgery: 0 fractional works · 2.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.5% of its workDermatology: 0 fractional works · 1.5% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workComplementary and alternative medicine: 0 fractional works · 0.7% of its workPhysical Sciences: 1 fractional works · 4.9% of its workComputer Science: 1 fractional works · 4.6% of its workComputational Theory and Mathematics: 1 fractional works · 4.6% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workALL ITS WORKAlzeCure Pharma(Sweden)12fractional works, all years
Life Sciences62%Physical Sciences5%Health Sciences33%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Neuroscience435.6%
    2. Biochemistry, Genetics and Molecular Biology325.7%
    3. Agricultural and Biological Sciences00.9%
    1. Medicine432.9%
    1. Computer Science14.6%
    2. Materials Science00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from AlzeCure Pharma (Sweden)?

The most cited paper from AlzeCure Pharma (Sweden) is "Neurotrophin-targeted therapeutics: A gateway to cognition and more?" (Gunnar Nordvall, Pontus K. A. Larsson Forsell, Johan Sandin, 2022), with 50 citations. Next come "Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis" (46) and "Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice" (45).

Most cited papers
#PaperReleasedCitations
1 Neurotrophin-targeted therapeutics: A gateway to cognition and more? Gunnar Nordvall, Pontus K. A. Larsson Forsell, Johan Sandin · Drug Discovery Today Open access 16 Jul 2022 50
2 Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis Hannes Odelram, Bengt Björkstén, T. AF KLERCKER et al. · Allergy Aug 1989 46
3 Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice Beatriz Merino, Cristina M. Fernández-Díaz, Cristina Parrado‐Fernández et al. · Metabolism Open access 9 Sep 2020 45
4 Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease Gunnar Nordvall, Johan Lundkvist, Johan Sandin · Frontiers in Molecular Neuroscience Open access 16 Oct 2023 39
5 Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling Luana Naia et al. · BMC Biology Open access 24 Mar 2021 39
All 25 most cited papers, with filters and sorting

Which research topics does AlzeCure Pharma (Sweden) publish most on?

By volume in 2022-now: Nerve injury and regeneration, Neuropeptides and Animal Physiology, Computational Drug Discovery Methods and Cancer, Stress, Anesthesia, and Immune Response.

Nerve injury and regener…1Nerve injury and regeneration: 1 fractional worksNeuropeptides and Animal…0Neuropeptides and Animal Physiology: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksCancer, Stress, Anesthes…0Cancer, Stress, Anesthesia, and Immune Response: 0 fractional worksPain Mechanisms and Treatments: 0 fractional worksNicotinic Acetylcholine Receptors Study: 0 fractional worksNeuroscience and Neuroph…0Neuroscience and Neuropharmacology Research: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional worksSignaling Pathways in Di…0Signaling Pathways in Disease: 0 fractional works
Cellular and Molecular NeuroscienceComputational Theory and MathematicsPsychiatry and Mental healthPhysiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nerve injury and regeneration Cellular and Molecular Neuroscience 1 works
  2. 2 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  4. 4 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
  5. 5 Pain Mechanisms and Treatments Physiology 0 works
  6. 6 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  7. 7 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
  8. 8 Alzheimer's disease research and treatments Physiology 0 works
  9. 9 Receptor Mechanisms and Signaling Molecular Biology 0 works
  10. 10 Signaling Pathways in Disease Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available82.2%not open17.8%

World: 40% of research is openly available.

with international co-authors11.6%domestic only88.4%

World: 18% is written across borders.

How has AlzeCure Pharma (Sweden)'s research output changed?

Output in 2022-2025 was 96% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AlzeCure Pharma (Sweden) as a percentage of every work published that year, 0.000027% in 2024.

still counting0.000020%0.000040%0.000060%AlzeCure Pharma (Sweden)0.000013% in 20251990200020102020

Fractional works of AlzeCure Pharma (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Huddinge

All research institutions in Huddinge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AlzeCure Pharma (Sweden). Posts are plain text and can be reported.